Short-term adverse events after COVAXIN vaccination in adolescents (15–18 Years) in Northern India: Frequency, predictors, and reporting behavior

Background: India initiated COVID-19 vaccination for adolescents (aged 15–18 years) on January 3, 2022, exclusively using COVAXIN. Adolescent-specific safety data remain limited, and adverse event following immunization (AEFI) reporting is notably low. This study evaluated the frequency, characteris...

全面介紹

書目詳細資料
發表在:Clinical Epidemiology and Global Health
Main Authors: Sujoy Bose, Arpita Bhriguvanshi, Mehul Saxena
格式: Article
語言:英语
出版: Elsevier 2025-07-01
主題:
在線閱讀:http://www.sciencedirect.com/science/article/pii/S221339842500171X

相似書籍